BORTEZOMIB RETREATMENT IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: RESULTS IN A COHORT OF 52 PATIENTS

被引：0
|
作者：
Canovas, A. [1 ]
Alonso, J. J. [2 ]
Barreiro, B. [2 ]
机构：
[1] UPV, Cruces Univ Hosp, Baracaldo, Vizcaya, Spain
[2] Osakidetza, Baracaldo, Vizacaya, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1601
引用
收藏
页码：617 / 618
页数：2
相关论文
共 50 条
  • [1] Bortezomib in relapsed or refractory multiple myeloma:: results in a cohort of 39 patients
    Canovas Fernandez, A.
    Alonso Alonso, J. J.
    Barreiro Garcia, J. G.
    Aguirre Errasti, C.
    [J]. REVISTA CLINICA ESPANOLA, 2008, 208 (04): : 187 - 192
  • [2] ANTITUMOR ACTIVITY OF BORTEZOMIB RETREATMENT IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA PATIENTS
    Skvortsova, N.
    Pospelova, T.
    Nechunaeva, I.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 590 - 590
  • [3] ANTITUMOR ACTIVITY OF BORTEZOMIB RETREATMENT IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA PATIENTS
    Skvortsova, N.
    Pospelova, T.
    Nechunaeva, I.
    Kovalchuk, S.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 616 - 616
  • [4] Clinical Outcome of Bortezomib Retreatment in Patients with Relapsed or Refractory Multiple Myeloma
    Ahn, Jae-Sook
    Jung, Sung-Hoon
    Lee, Seung-Shin
    Ahn, Seo-Yeon
    Yang, Deok-Hwan
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [5] Response to bortezomib in relapsed/refractory multiple myeloma cohort
    Rubio-Martinez, A.
    Recasens, V.
    Montanes, M. A.
    Mayayo, P.
    Delgado, P.
    Garcia-Zueco, J. C.
    Rubio-Felix, D.
    Giraldo, P.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 472 - 472
  • [6] Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma
    Cerchione, Claudio
    Nappi, Davide
    Di Perna, Maria
    Zacheo, Irene
    Pareto, Anna Emanuele
    Picardi, Marco
    Catalano, Lucio
    Pane, Fabrizio
    [J]. CASE REPORTS IN HEMATOLOGY, 2016, 2016
  • [7] Bortezomib in Relapsed/Refractory Multiple Myeloma
    Shen, Z.
    Wang, L.
    Yan, H.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S62 - S62
  • [8] Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practice
    Hulin, Cyrille
    de la Rubia, Javier
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Katodritou, Eirini
    Hungria, Vania
    De Samblanx, Hadewijch
    Stoppa, Anne-Marie
    Aagesen, Jesper
    Sargin, Deniz
    Sioni, Anastasia
    Belch, Andrew
    Diels, Joris
    Olie, Robert A.
    Robinson, Don, Jr.
    Potamianou, Anna
    van de Velde, Helgi
    Delforge, Michel
    [J]. HEALTH SCIENCE REPORTS, 2019, 2 (01)
  • [9] Effective response with bortezomib retreatment in relapsed multiple myeloma
    Taverna, Christian
    Voegeli, Jerome
    Trojan, Andreas
    Olie, Robert A.
    von Rohr, Albert
    [J]. SWISS MEDICAL WEEKLY, 2012, 142
  • [10] Correlating response to bortezomib in relapsed/refractory multiple myeloma to adverse cytogenetics: Results of a Canadian cohort
    Mikhael, J.
    Reece, D.
    Belch, A.
    Bahlis, N.
    Sharma, D.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 164 - 164
12345